Small molecules that perturb developmental signaling pathways can have devastating effects on embryonic patterning, as evidenced by the chemically induced onset of cyclopic lambs and children with severely shortened limbs during the 1950s. Recent studies, however, have revealed critical roles for these pathways in human disorders and diseases, spurring the re-examination of these compounds as new targeted therapies. In this tutorial review, we describe four case studies of teratogenic compounds, including inhibitors of the Hedgehog (Hh), Wnt, and bone morphogenetic protein (BMP) pathways. We discuss how these teratogens were discovered, their mechanisms of action, their utility as molecular probes, and their potential as therapeutic agents. We also consider current challenges in the field and possible directions for future research.
    
         
            
                     
                    
                        
                            
                                You have access to this article
                            
                            
                                
                                    
                                        
                                             Please wait while we load your content...
                                        
                                        
                                            Something went wrong. Try again?
                                            Please wait while we load your content...
                                        
                                        
                                            Something went wrong. Try again?